Robert Burgess

Robert Burgess is a Professor in the Graduate School of Biomedical Science and Engineering at the University of Maine, with a primary affiliation in Neuroscience. He holds a B.S. in Biochemistry from Michigan State University (1990) and a Ph.D. in Neuroscience from Stanford University (1996). His research focuses on understanding molecular mechanisms underlying synapse formation and maintenance, particularly at neuromuscular junctions and retinal synapses. His lab investigates neurodevelopmental and neuromuscular disorders, including Charcot-Marie-Tooth disease and other neuropathies, using mouse models and molecular genetics approaches. His work is funded by the Muscular Dystrophy Association and the NIH.

Key research areas include synaptic connectivity, axonal degeneration, and the role of tRNA synthetases in neurodegeneration. He has published extensively on mechanisms of peripheral neuropathy and has developed multiple mouse models to study these conditions. His contributions include identifying genetic modifiers of neuropathic diseases and exploring therapeutic interventions such as gene therapy for Charcot-Marie-Tooth type 4J.

Burgess leads the Neuroscience curriculum and serves on the curriculum committee. His laboratory collaborates widely, integrating genetic, cellular, and molecular approaches to address fundamental questions in neurobiology and translational medicine.